Home › Clear-cell metastatic renal cell carcinoma › Tennessee › Nashville
Clear-cell metastatic renal cell carcinoma clinical trials in Nashville, TN
5 studies for Clear-cell metastatic renal cell carcinoma are looking for participants at sites in and around Nashville (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma
RecruitingPhase 3
- Research Site, Nashville
- Research Site, Nashville
Casdatifan for the Treatment of Refractory Metastatic Clear Cell Renal Cell Carcinoma
RecruitingPhase 1
- Vanderbilt University Medical Center, Nashville
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
RecruitingPhase 1/2
- Sarah Cannon Research Institute, Nashville
- SCRI Oncology Partners, Nashville
- Tennessee Oncology, PLLC- Elliston Place Plaza, Nashville
- and 11 more
Genetic Testing to Select Therapy for the Treatment of Advanced or Metastatic Kidney Cancer, OPTIC RCC Study
RecruitingPhase 2
- Vanderbilt University/Ingram Cancer Center, Nashville
A First-in-Human Study of BMS-986506 in Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC)
RecruitingPhase 1
- SCRI Oncology Partners, Nashville
Clear-cell metastatic renal cell carcinoma trials in other cities
- Baldwin Park, CA7 studies
- New York City, NY5 studies
- Dallas, TX5 studies
- Rochester, MN4 studies
- Cleveland, OH4 studies
- Waukegan, IL4 studies
- St. Louis, MO4 studies
- Ann Arbor, MI3 studies
- San Francisco, CA3 studies
- San Diego, CA3 studies
- Houston, TX3 studies
- Queens, NY3 studies
Other studies in Nashville
- Non-Small Cell Lung Cancer97 studies
- Breast Cancer81 studies
- Metastatic Cancer70 studies
- Colorectal Cancer69 studies
- Cancer (all types)65 studies
- Ovarian Cancer49 studies
- Prostate Cancer43 studies
- Lung Cancer40 studies
- Head and Neck Squamous Cell Carcinoma39 studies
- Pancreatic Cancer39 studies
- Endometrial Cancer38 studies
- Melanoma33 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.